QTORIN 3.9% Rapamycin Anhydrous Gel
PALV-09
Phase 3 small_molecule active
Quick answer
QTORIN 3.9% Rapamycin Anhydrous Gel for Microcystic Lymphatic Malformation is a Phase 3 program (small_molecule) at PALVELLA THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PALVELLA THERAPEUTICS, INC.
- Indication
- Microcystic Lymphatic Malformation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active